What It Is

Tirzepatide is a once-weekly injectable medication that helps manage blood sugar levels in people with type 2 diabetes and also aids in weight loss for individuals with obesity. Think of it as a smart key that unlocks two different doors (GIP and GLP-1 receptors) in your body to help control appetite and insulin.

Main Benefits

How It’s Typically Used

Tirzepatide is administered as a subcutaneous (under the skin) injection once a week. The dosage usually starts low and is gradually increased over several weeks to minimize side effects. It’s meant to be used alongside a healthy diet and regular exercise.

Potential Downsides

Common side effects are often gastrointestinal, including nausea, diarrhea, vomiting, and constipation, especially when first starting the medication. In rare cases, it may increase the risk of thyroid tumors or pancreatitis. It’s important to use this medication under the supervision of a doctor.

Who Might Consider This?

Adults with type 2 diabetes who need better blood sugar control, or individuals with obesity (or who are overweight with a related health condition) who are looking for a medical weight loss solution.

Tirzepatide vs. Semaglutide

Feature Tirzepatide Semaglutide
Mechanism Dual GIP and GLP-1 receptor agonist GLP-1 receptor agonist only
Primary Use Type 2 Diabetes & Weight Loss Type 2 Diabetes & Weight Loss
Avg. Weight Loss Up to 22.5% Around 15-17%
Administration Once-weekly injection Once-weekly injection or daily pill

Compound Details

CAS Number 2023788-19-2
Molecular Formula C225H348N48O68
Sequence Not readily available in a simple format
PubChem CID 156598379
PubChem Link 156598379